Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in <i>ROS1</i> Fusion–Positive Lung CancerJustin F. Gainor, Christina J. Falcon, Jennifer Peterson et al.|Clinical Cancer Research|2021Cited by 137